SPRY4 and central nervous system cancer: As depicted in Figure 4E, the results demonstrated that CM from SPRY4‐IT1‐knockdown glioma cells significantly decreased HUVECs migration distance, and CM from SPRY4‐IT1‐overexpressed glioma cells markedly increased HUVECs migration distance (Figure 4E,F).